Dr. Lotan on the iodine-based contrast media shortage

Video

“For patients who are several years out from treatment for bladder cancer or kidney cancer, I don't think [the shortage is] going to have a clinical impact. For more acute settings, I have tried to rely a little bit more on MR urograms and ultrasound,” says Yair Lotan, MD.

In this interview, Yair Lotan, MD, is a professor of urology, chief of Urologic Oncology, the Jane and John Justin Distinguished Chair in Urology, in honor of Claus G. Roehrborn, MD, and vice chair of clinical affairs at the University of Texas Southwestern Medical Center in Dallas.

Related Videos
Nicholas L. Kavoussi, MD, answers a question during a Zoom video interview
Doctor typing on computer | Image Credit: © smolaw11 - stock.adobe.com
Christopher J.D. Wallis, MD, PhD, answers a question during a Zoom video interview
3d rendered illustration of bladder cancer | Image Credit: © SciePro - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Conference of doctors | Image Credit:  ©  Aydan - stock.adobe.com
Udit Singhal, MD, answers a question during a zoom video interview
Randall A. Lee, MD, answers a question during a Zoom video interview
Related Content
© 2023 MJH Life Sciences

All rights reserved.